Covid19, Follow up, Rehabilitation
Conditions
Keywords
SARS-CoV-2, Follow up, Intensive care unit, Cohort
Brief summary
Patients affected by new coronavirus infectious disease (COVID) were mostly hospitalized in ICU. This infection seems to cause widespread organ injury (i.e acute renal injury, neurological disorders, pulmonary embolism,…). It is therefore necessary to provide a framework for the follow up of patients. Moreover SARS-CoV-2 infection consequences remain unknow at this time. Study hypothesis is that COVID alters determining factors (physical or psychological) of quality of life after ICU hospitalisation. The aim of the study is to assess quality of life 3 months after ICU hospitalization. Secondary purposes of the study are 1) assessment of quality of life 6 months and the evolution between the third and the sixth months after ICU hospitalization 2) description patients care after 3 and 6 months ICU left and their clinical status 3) convening and providing a platform within several physicians (neurologist, biologist, pneumologist…) will be able to follow up patients and perform complementary investigations according to patients injuries.
Interventions
OTHERquality of live assessment
quality of live assessment 3 moth and 6 moth after ointensive care hospitalisation using SF36.
Sponsors
University Hospital, Strasbourg, France
Study design
Observational model
COHORT
Time perspective
PROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes
Inclusion criteria
* Subject male or female ≥ 18 years old * Patient hospitalized in the anesthesia-resuscitation department of the NHC for COVID-19 from March 1, 2020. * Patient (or his legal representative) having given his consent for the use of his data for the purposes of this research.
Exclusion criteria
* Subject not hospitalized in intensive care * Patient's refusal to participate in the study * Inability to give informed information to the subject (subject in an emergency, difficulty understanding the subject, etc.) * Subject under low protection
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| assess quality of life after severe COVID infection | measured at 3 months after ICU left. | assess different dimensions of quality of life: physical and mentaland social dimensions |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Quality of life and Clinical status | measured at 3 and 6 months after ICU left. | Clinical status of patients and assessment of quality of life. collects crucial elements of care based on doctors' prescriptions |
Countries
France
Outcome results
None listed